This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
Depomed, Inc., a specialty pharmaceutical company, develops products for pain and other central nervous system conditions in the United States.View DEPO key stats
DepoMed Inc - DEPO - EQUITY
Reviewed By: TheStreet Ratings on .
Report Summary: TheStreet Ratings team rates DepoMed Inc as a
Buy with a ratings score of B-.
Report Snippet: We rate DEPOMED INC (DEPO) a BUY. This is driven by a few notable strengths, which we believe should have a greater impact than any weaknesses, and should give investors a better performance opportunity than most stocks we cover. The company's strengths can be seen in multiple areas, such as its robust revenue growth, solid stock price performance, good cash flow from operations and expanding profit margins. We feel its strengths outweigh the fact that the company has had sub par growth in net income.